Nifty
Sensex
:
:
11709.10
38969.80
-119.15 (-1.01%)
-382.87 (-0.97%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 524372 | NSE: ORCHIDPHAR

4.88
0.23 (4.95%)
21-May-2019 | 4:01PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  4.87
  •  4.88
  •  4.43
  •  4.65
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  73308
  •  3.58
  •  10.50
  •  3.04

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 43.06
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,939.46
  • N/A
  • -0.05

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 26.68%
  • 5.63%
  • 61.03%
  • FII
  • DII
  • Others
  • 0.03%
  • 3.70%
  • 2.93%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -5.96
  • -
  • -9.85

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -17.82
  • -
  • -33.75

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 21.15
  • -
  • 9.01

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.88
  • 0.92
  • 0.44

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 28.32
  • 37.02
  • 50.65

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Net Sales
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Sep 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Net Sales
-
682.98
796.50
873.44
1,746.61
1,947.70
1,873.60
1,781.79
2,358.76
1,296.85
1,300.96
Net Sales Growth
-
-14.25%
-8.81%
-49.99%
-10.32%
3.95%
5.15%
-24.46%
81.88%
-0.32%
 
Cost Of Goods Sold
-
350.20
393.46
400.96
779.03
990.12
876.31
868.89
795.29
547.45
441.36
Gross Profit
-
332.79
403.05
472.47
967.58
957.58
997.29
912.90
1,563.47
749.40
859.61
GP Margin
-
48.73%
50.60%
54.09%
55.40%
49.16%
53.23%
51.23%
66.28%
57.79%
66.08%
Total Expenditure
-
658.68
709.37
702.65
1,429.32
1,837.44
1,516.99
1,433.68
1,500.34
1,126.28
961.02
Power & Fuel Cost
-
50.69
54.33
55.28
102.19
121.72
89.14
76.80
70.58
77.55
72.90
% Of Sales
-
7.42%
6.82%
6.33%
5.85%
6.25%
4.76%
4.31%
2.99%
5.98%
5.60%
Employee Cost
-
86.22
80.25
86.81
193.82
252.70
176.41
164.73
174.48
137.46
117.14
% Of Sales
-
12.62%
10.08%
9.94%
11.10%
12.97%
9.42%
9.25%
7.40%
10.60%
9.00%
Manufacturing Exp.
-
65.65
87.40
94.33
182.40
226.41
198.70
150.32
176.73
156.91
169.37
% Of Sales
-
9.61%
10.97%
10.80%
10.44%
11.62%
10.61%
8.44%
7.49%
12.10%
13.02%
General & Admin Exp.
-
41.49
40.99
31.10
91.62
93.40
76.95
92.71
113.80
68.19
67.89
% Of Sales
-
6.07%
5.15%
3.56%
5.25%
4.80%
4.11%
5.20%
4.82%
5.26%
5.22%
Selling & Distn. Exp.
-
22.10
45.73
27.73
51.28
55.52
63.26
55.06
44.17
50.71
50.57
% Of Sales
-
3.24%
5.74%
3.17%
2.94%
2.85%
3.38%
3.09%
1.87%
3.91%
3.89%
Miscellaneous Exp.
-
42.34
7.21
6.44
28.97
97.57
36.21
25.17
125.30
88.00
50.57
% Of Sales
-
6.20%
0.91%
0.74%
1.66%
5.01%
1.93%
1.41%
5.31%
6.79%
3.21%
EBITDA
-
24.30
87.13
170.79
317.29
110.26
356.61
348.11
858.42
170.57
339.94
EBITDA Margin
-
3.56%
10.94%
19.55%
18.17%
5.66%
19.03%
19.54%
36.39%
13.15%
26.13%
Other Income
-
20.30
19.17
24.91
42.47
40.72
56.19
53.02
8.59
86.05
71.30
Interest
-
310.26
331.11
294.24
537.12
522.69
179.75
116.75
242.27
156.45
82.00
Depreciation
-
133.31
141.02
145.27
324.58
251.92
153.74
133.50
154.90
133.99
100.68
PBT
-
-398.96
-365.82
-243.82
-501.95
-623.63
79.32
150.87
469.83
-33.82
228.56
Tax
-
-46.19
-48.04
-17.25
-191.46
-12.52
-22.04
15.38
130.58
15.17
53.23
Tax Rate
-
11.58%
8.92%
5.82%
49.27%
2.19%
-29.22%
8.96%
27.79%
-44.86%
23.29%
PAT
-
-352.77
-490.49
-279.11
-196.51
-558.02
97.48
156.19
339.25
-48.99
175.34
PAT before Minority Interest
-
-352.77
-490.49
-279.11
-197.13
-559.99
97.48
156.19
339.25
-48.99
175.34
Minority Interest
-
0.00
0.00
0.00
0.62
1.97
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
-51.65%
-61.58%
-31.96%
-11.25%
-28.65%
5.20%
8.77%
14.38%
-3.78%
13.48%
PAT Growth
-
-
-
-
-
-
-37.59%
-53.96%
-
-
 
Unadjusted EPS
-
-39.65
-55.13
-32.07
-26.88
-79.21
13.84
22.17
48.16
-7.14
26.63

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Sep 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Shareholder's Funds
-791.76
-387.67
49.04
329.39
379.99
1,132.30
1,069.24
937.66
633.80
664.98
Share Capital
88.96
88.96
88.96
85.26
70.45
70.44
70.44
70.44
70.44
65.85
Total Reserves
-880.72
-476.63
-39.92
244.12
309.53
1,061.86
998.80
867.22
563.36
599.13
Non-Current Liabilities
1,904.62
2,204.95
2,475.41
2,609.35
1,064.40
1,251.94
849.66
1,864.07
2,744.32
2,085.45
Secured Loans
1,893.91
2,156.78
2,377.54
2,493.95
901.79
1,074.15
604.06
1,035.91
1,714.11
979.56
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
625.36
901.74
990.98
Long Term Provisions
7.48
2.07
3.73
4.18
5.24
7.72
9.64
0.00
0.00
0.00
Current Liabilities
2,012.51
1,540.72
1,337.62
1,122.66
3,206.03
1,551.05
1,989.41
971.83
855.83
733.80
Trade Payables
358.79
424.52
374.27
311.15
597.40
447.00
335.16
318.21
390.10
296.23
Other Current Liabilities
958.40
476.24
285.34
112.64
1,052.57
406.96
1,005.23
293.78
369.16
359.23
Short Term Borrowings
694.29
599.52
633.79
646.64
1,524.89
647.06
489.86
0.00
0.00
0.00
Short Term Provisions
1.03
40.44
44.22
52.23
31.17
50.03
159.16
359.84
96.58
78.34
Total Liabilities
3,125.37
3,358.00
3,862.07
4,061.40
4,651.04
3,938.11
3,910.23
3,773.56
4,233.95
3,484.23
Net Block
1,386.20
1,496.54
1,636.83
1,795.20
2,583.57
2,073.88
1,741.76
1,603.31
2,007.51
1,539.95
Gross Block
1,659.50
3,005.92
3,005.87
3,002.15
3,772.17
3,089.68
2,613.62
2,344.63
2,695.66
2,098.12
Accumulated Depreciation
273.30
1,509.38
1,369.04
1,206.95
1,188.60
1,015.80
871.86
741.32
688.16
558.17
Non Current Assets
2,446.42
2,478.86
2,610.87
2,783.27
3,549.62
2,684.83
2,383.94
2,072.24
2,554.21
2,160.07
Capital Work in Progress
271.53
288.31
280.40
281.51
360.42
352.25
332.29
468.92
546.70
620.12
Non Current Investment
1.07
0.96
0.81
0.81
0.95
0.81
0.81
0.00
0.00
0.00
Long Term Loans & Adv.
777.64
685.17
680.83
681.63
576.08
219.66
287.82
0.00
0.00
0.00
Other Non Current Assets
9.98
7.88
12.00
24.12
28.60
38.23
21.26
0.00
0.00
0.00
Current Assets
678.94
879.14
1,251.20
1,278.12
1,101.42
1,253.29
1,526.30
1,701.32
1,596.17
1,324.16
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.81
0.81
0.81
Inventories
193.74
211.25
241.85
251.93
506.24
668.73
617.63
422.64
768.25
649.15
Sundry Debtors
119.51
203.00
310.07
256.57
179.06
113.24
513.48
736.98
672.54
537.94
Cash & Bank
305.55
257.06
314.94
390.56
23.42
176.92
201.08
335.16
52.51
31.04
Other Current Assets
60.14
9.46
116.72
105.80
392.69
294.41
194.12
205.73
102.06
105.21
Short Term Loans & Adv.
40.31
198.36
267.62
273.26
378.34
278.33
184.86
201.40
96.97
101.66
Net Current Assets
-1,333.57
-661.58
-86.42
155.46
-2,104.61
-297.76
-463.11
729.49
740.34
590.36
Total Assets
3,125.36
3,358.00
3,862.07
4,061.39
4,651.04
3,938.12
3,910.24
3,773.56
4,233.96
3,484.23

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Sep 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Cash From Operating Activity
9.18
317.01
212.20
-369.07
168.17
737.02
332.13
-34.32
45.90
210.29
PBT
-398.96
-452.28
-296.18
-243.29
-572.51
75.44
171.57
469.83
-33.82
228.56
Adjustment
453.49
582.11
490.19
1,006.39
661.19
333.54
214.51
-557.33
199.78
132.43
Changes in Working Capital
-38.31
187.17
18.19
-669.27
79.49
356.82
7.24
119.07
-117.26
-118.42
Cash after chg. in Working capital
16.22
317.01
212.20
93.84
168.17
765.80
393.31
31.57
48.71
242.57
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-7.04
0.00
0.00
-47.03
0.00
-28.78
-61.18
-65.89
-2.81
-32.28
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
-415.87
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-28.06
-8.59
-1.46
1,333.66
-986.04
-293.05
-367.41
1,412.76
-476.97
-545.40
Net Fixed Assets
1,346.74
-7.97
-2.38
848.92
-751.02
-494.66
-121.72
428.65
-504.48
-594.63
Net Investments
-0.11
-0.01
0.00
-0.47
24.72
-18.48
-6.85
-1.20
-8.55
1.89
Others
-1,374.69
-0.61
0.92
485.21
-259.74
220.09
-238.84
985.31
36.06
47.34
Cash from Financing Activity
33.39
-366.30
-286.36
-597.44
664.38
-480.15
-77.75
-1,076.81
431.08
247.36
Net Cash Inflow / Outflow
14.51
-57.88
-75.62
367.14
-153.49
-36.17
-113.03
301.64
0.02
-87.75
Opening Cash & Equivalents
20.60
314.94
390.56
23.42
176.92
213.09
326.13
24.49
24.47
112.22
Closing Cash & Equivalent
35.11
257.06
314.94
390.56
23.42
176.92
213.09
326.13
24.49
24.47

Financial Ratios

Consolidated /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Sep 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Book Value (Rs.)
-89.00
-43.58
5.51
38.63
53.94
160.74
151.79
133.11
78.11
100.98
ROA
-10.88%
-13.59%
-7.05%
-4.53%
-13.04%
2.48%
4.07%
8.47%
-1.27%
5.50%
ROE
0.00%
0.00%
-147.51%
-55.58%
-74.06%
8.86%
15.56%
45.60%
-8.06%
30.49%
ROCE
-3.46%
-6.93%
-0.06%
4.17%
-1.48%
8.12%
10.03%
24.70%
4.23%
13.02%
Fixed Asset Turnover
0.29
0.27
0.29
0.52
0.57
0.66
0.73
0.94
0.55
0.72
Receivable days
85.57
115.97
116.98
45.27
27.22
60.58
126.84
108.66
168.81
128.10
Inventory Days
107.46
102.41
101.94
78.79
109.43
124.35
105.52
91.80
197.67
175.34
Payable days
198.57
186.30
148.72
86.46
100.90
89.04
77.18
87.92
107.36
90.80
Cash Conversion Cycle
-5.54
32.07
70.20
37.60
35.76
95.89
155.18
112.54
259.12
212.65
Total Debt/Equity
-4.04
-8.01
65.54
9.75
8.43
1.77
1.94
1.77
4.75
2.96
Interest Cover
-0.29
-0.63
-0.01
0.28
-0.10
1.42
2.47
2.94
0.78
3.79

News Update:


  • Orchid Pharma gets nod from USFDA for Risedronate Sodium Tablets
    14th May 2019, 16:42 PM

    Risedronate sodium tablets are a bisphosphonate indicated for the treatment and prevention of Osteoporosis

    Read More
  • Orchid Pharma - Quarterly Results
    13th Feb 2019, 12:43 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.